Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million
- Regeneron Pharmaceuticals announced on May 19, 2025, that it will buy 23andMe Holding Co. for $256 million in a bankruptcy auction based in San Francisco.
- The acquisition follows 23andMe’s Chapter 11 bankruptcy filing in March, after which a court-supervised auction required bidders to comply with privacy policies due to customer data concerns.
- Regeneron plans to purchase nearly all of 23andMe’s assets, excluding the Lemonaid Health telehealth division, which 23andMe intends to gradually discontinue, while upholding existing privacy safeguards and ensuring data security.
- The transaction includes 23andMe’s Personal Genome Service and Health and Research Services used by 15 million customers providing saliva samples, despite a 2023 data breach and declining ancestry testing demand.
- The deal is subject to U.S. Bankruptcy Court approval and other closing conditions, with a hearing scheduled for June 17, 2025, and expected closing in the third quarter of 2025.
203 Articles
203 Articles
Todayville
LifeSiteNewsBig Pharma company Regeneron buys 23andMe, set to acquire genetic data of millions
From LifeSiteNews Regeneron said it will act ethically when it acquires data on 15 million Americans from 23andMe. A Big Pharma company will acquire genetic data on 15 million people after purchasing DNA testing company 23andMe in a bankruptcy auction. “Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction,” CNN reported. “Regeneron said it will comply with 23andMe’s privacy polic…
Your DNA Data Sold: 23andMe's Big Deal with Regeneron Raises Privacy Concerns
Genetic information submitted by millions of 23andMe users is now in the hands of pharmaceutical giant Regeneron, following a £200 million acquisition deal. Originally provided by customers seeking personal health or ancestry insights, the data may now be used to develop new drugs — with limited control or consent from the individuals it came from. The Sale That Shook Consumer Genetics In a shocking deal, it was announced that Regeneron would ac…
Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data
(Reuters) - Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of
Regeneron acquires bankrupt DNA testing startup 23andMe and its data for $256 million - Tech Startups
Regeneron Pharmaceuticals announced Monday that it’s buying “substantially all” of 23andMe’s assets for $256 million. The deal comes just weeks after the once buzzy DNA testing startup, once valued near $6 billion, filed for Chapter 11 bankruptcy. According to Regeneron, […] The post Regeneron acquires bankrupt DNA testing startup 23andMe and its data for $256 million first appeared on Tech Startups.
NC residents have less than 2 months to file claim against 23andMe - WCCB Charlotte's CW
CHARLOTTE, N.C. – People living in North Carolina have less than two months to file claims against 23andMe over the company’s 2023 security breach. NC Attorney General Jeff Jackson was investigating 23andMe over the data breach when the company filed for bankruptcy protection. You’re eligible to file a claim if you meet one of three criteria: -You were a 23andMe customer between May and October of 2023 You received notice that your personal info…
Coverage Details
Bias Distribution
- 66% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
